Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.69 |
| ▸ | AHR | P35869 | 2/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.54 |
| ▸ | PCSK9 | Q8NBP7 | 5/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.52 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29403791 | 1.00 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL28338445 | 1.00 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL28335219 | 0.98 | LOXL2 (0.67) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL7169246 | 0.91 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL31059889 | 0.91 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL30105384 | 0.87 | LOXL2 (0.60) | LOXL2AHRPCSK9 | |
| SCHEMBL3193871 | 0.87 | LOXL2 (0.60) | LOXL2AHRPCSK9 | |
| SCHEMBL17508513 | 0.87 | AHR (0.55) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL6860219 | 0.86 | LOXL2 (0.64) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| Bromide SCHEMBL30437340 | 0.86 | LOXL2 (0.58) | LOXL2AHRPCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2090 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137715-A1 | AQUEOUS FORMULATION INCLUDING DISSOLVED HYDROGEN GAS AND MINERALS AND ADDITIVES | BEST PLANET SCIENCE LLC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-12527765-B2 | Composition comprising a diindolylmethane and a retinoid to treat a skin condition | SKINTECH LIFE SCIENCE LIMITED (GB) | 2026-01-20 | — | — | US | claimed |
| US-12527804-B2 | Microemulsion delivery systems for alcohol-soluble species including DHEA, pregnenolone, and chrysin for reducing menopausal symptoms | Quicksilver Scientific, Inc. (US) | 2026-01-20 | — | — | US | claimed |
| EP-4676470-A2 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250339680-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2025-11-06 | — | — | US | claimed |
| WO-2025151636-A2 | SPRINKLE PREPARATIONS | VITAKEY INC. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025133964-A1 | A NUTRACEUTICAL FORMULATION TO TREAT HORMONAL IMBALANCES AND MENSTRUAL DISORDERS | PATODIA RAMESH (IN) | 2025-06-26 | — | — | WO | claimed |
| WO-2003034992-A2 | DIINDOLYLMETHANE FOR THE TREATMENT OF HPV INFECTION | BIORESPONSE, L.L.C. (US) | 2003-05-01 | — | — | WO | claimed |
| US-6544564-B1 | Cytotoxic pharmaceutical composition | FARLEY MICHAEL DONALD (US) | 2003-04-08 | — | — | US | claimed |
| WO-2002080906-A1 | PREVENTION AND TREATMENT OF ENDOMETRIOSIS WITH ARYL HYDROCARBON RECEPTOR BINDING LIGANDS | CEDARS-SINAI MEDICAL CENTER (US) | 2002-10-17 | — | — | WO | claimed |
| US-20020147155-A1 | Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands | CEDARS-SINAI MEDICAL CENTER | 2002-10-10 | — | — | US | claimed |
| US-6399645-B1 | Chemoprevention and treatment of cervical or vaginal neoplasia | BELL MARIA (US) | 2002-06-04 | — | — | US | claimed |
| US-20020058648-A1 | Estrogenic substances combined with cruciferous indole compounds | HAMMERLY MILTON (US) | 2002-05-16 | — | — | US | claimed |
| WO-2002028832-A2 | DIINDOLYLMETHANE AND C-SUBSTITUTED DIINDOLYLMETHANE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE CANCERS | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2002-04-11 | — | — | WO | claimed |
| EP-1067913-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | Bioresponse, L.L.C. (US) | 2001-01-17 | — | — | EP | claimed |
| US-6086915-A | HEATING THE SOLUBILIZING EMULSIFIER, ADDING SOLVENT AND ONE OR MORE PHOSPHOLIPID SURFACTANTS, DISSOLVING IN THIS SOLUTION ONE OR MORE HYDROPHOBIC PHYTOCHEMICALS, ADDING ENCAPSULATORS, FORMING MICROEMULSION, SPRAY DRYING THE SOLUTION | BIORESPONSE L.L.C. (US) | 2000-07-11 | — | — | US | claimed |
| WO-1999049851-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE, L.L.C. (US) | 1999-10-07 | — | — | WO | claimed |